ArticleMedicina (Kaunas, Lithuania)2026

Prognostic Value of Treatment-Related Body Composition Changes in Metastatic NSCLC Receiving Nivolumab.

Erkam Kocaaslan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.